安徽医学
安徽醫學
안휘의학
ANHUI MEDICAL JOURNAL
2014年
12期
1699-1701,1702
,共4页
张华东%姚子峰%丁晓勇%丁海东%刘志阔%余辉
張華東%姚子峰%丁曉勇%丁海東%劉誌闊%餘輝
장화동%요자봉%정효용%정해동%류지활%여휘
骨质疏松%椎体骨折%经皮椎体成形术%抗骨质疏松治疗
骨質疏鬆%椎體骨摺%經皮椎體成形術%抗骨質疏鬆治療
골질소송%추체골절%경피추체성형술%항골질소송치료
Osteoporosis%Vertebral fracture%Percutaneous vertebroplasty%Anti osteoporosis treatment
目的:观察经皮椎体成形术联合抗骨质疏松药治疗骨质疏松性椎体压缩性骨折的疗效。方法50例骨质疏松引起的椎体压缩性骨折患者进行经椎体成形术治疗,术后给予抗骨质疏松药物治疗,分别在治疗前、治疗后24 h、1周、1个月、3个月及6个月进行视觉模拟评分并观察疼痛缓解优良率。结果患者治疗前与术后24 h、术后1周、1个月的 VAS 评分差异有统计学意义(P <0.05);术后1个月与3个月、6个月的 VAS 评分差异无统计学意义(P >0.05)。患者中优29例(58.00%),良19例(38.00%),差2例(4.00%),优良率为96.00%。结论经椎体成形术联合抗骨质疏松药治疗骨质疏松性椎体压缩性骨折能够更好的缓解患者的疼痛,预防相邻椎体再骨折,提高患者的生活质量,值得临床推广。
目的:觀察經皮椎體成形術聯閤抗骨質疏鬆藥治療骨質疏鬆性椎體壓縮性骨摺的療效。方法50例骨質疏鬆引起的椎體壓縮性骨摺患者進行經椎體成形術治療,術後給予抗骨質疏鬆藥物治療,分彆在治療前、治療後24 h、1週、1箇月、3箇月及6箇月進行視覺模擬評分併觀察疼痛緩解優良率。結果患者治療前與術後24 h、術後1週、1箇月的 VAS 評分差異有統計學意義(P <0.05);術後1箇月與3箇月、6箇月的 VAS 評分差異無統計學意義(P >0.05)。患者中優29例(58.00%),良19例(38.00%),差2例(4.00%),優良率為96.00%。結論經椎體成形術聯閤抗骨質疏鬆藥治療骨質疏鬆性椎體壓縮性骨摺能夠更好的緩解患者的疼痛,預防相鄰椎體再骨摺,提高患者的生活質量,值得臨床推廣。
목적:관찰경피추체성형술연합항골질소송약치료골질소송성추체압축성골절적료효。방법50례골질소송인기적추체압축성골절환자진행경추체성형술치료,술후급여항골질소송약물치료,분별재치료전、치료후24 h、1주、1개월、3개월급6개월진행시각모의평분병관찰동통완해우량솔。결과환자치료전여술후24 h、술후1주、1개월적 VAS 평분차이유통계학의의(P <0.05);술후1개월여3개월、6개월적 VAS 평분차이무통계학의의(P >0.05)。환자중우29례(58.00%),량19례(38.00%),차2례(4.00%),우량솔위96.00%。결론경추체성형술연합항골질소송약치료골질소송성추체압축성골절능구경호적완해환자적동통,예방상린추체재골절,제고환자적생활질량,치득림상추엄。
Objective To observe the curative effect of the percutaneous vertebroplasty(PVP)combined with anti osteoporosis drug treatment for osteoporotic vertebral compression fractures(OVCF).Methods Fifty patients with OVCF underwent PVP,and given anti osteo-porosis drug therapy after operation.Visual analogue score(VAS)and the excellent rate of pain relief before treatment and after treatment at different time points were evaluated.Results The VAS score of patients before treatment and different time points after treatment had signifi-cant differences(P <0.05),but there was no significant difference between 1 month and 3 months,6 months of postoperative (P >0.05).Patients were excellent in 29 cases(58.00%),good in 19 cases(38.00%),and poor in 2 cases(4.00%),with the excellent rate of 96.00%.Conclusion Percutaneous vertebroplasty combined anti osteoporosis drug in the treatment of OVCF can alleviate the pain,prevent adjacent vertebral fractures again,and improve the quality of life for the patients.